Type 2 diabetes Archives -

AZ’s Forxiga gets heart claim data on its EU label

https://pharmaphorum.com/news/azs-forxiga-gets-heart-claim-data-on-its-eu-label/

Novo Nordisk’s Victoza gets FDA okay for paediatric use

https://pharmaphorum.com/news/novo-nordisks-victoza-fda-paediatric-use/

Beyond glucose in type 2 diabetes: how Novo Nordisk is looking to address chronic kidney disease

https://pharmaphorum.com/r-d/views-analysis-r-d/beyond-glucose-in-type-2-diabetes-how-novo-nordisk-is-looking-to-address-chronic-kidney-disease/

Trial sets up 2020 filing for Poxel’s novel diabetes drug

https://pharmaphorum.com/news/trial-sets-up-2020-filing-for-poxels-novel-diabetes-drug/

Type 2 diabetes research: fewer side effects from modified medication

https://pharmaphorum.com/news/diabetes-research-modified-medication/

Novo’s diabetes pill beats injections in head-to-head trials

https://pharmaphorum.com/news/novo-nordisks-success-with-oral-diabetes-drug/

Trulicity helps SGLT-2 patients lower blood sugar

https://pharmaphorum.com/news/trulicity-sglt-2-drug-combo-doesnt-boost-blood-sugar-lowering/

Novo aims for GLP-1 sales growth in China

https://pharmaphorum.com/news/novo/

Novo highlights key ‘hypo’ data from Tresiba at EASD

https://pharmaphorum.com/news/novo-highlights-key-hypo-data-easd/

Search